Aquiline Capital Partners (Aquiline), a private investment firm with over $10bn in AUM, has made a majority investment in PharmaForce, a pharmacy solutions provider to hospitals and health clinics. Financial terms of the deal have not been disclosed.
The provider has delivered 340B administration software to over 280 clients since its inception in 2017 and recently launched a pharmacy benefits management offering.
In a press statement, PharmaForce said that, with Aquiline’s backing, it will “accelerate strategic M&A and continue to expand its product capabilities”.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Piper Sandler served as financial advisor to PharmaForce. Legal counsel was provided by Taft and Ropes & Gray to PharmaForce and Aquiline respectively.
Source: Private Equity Wire
Can’t stop reading? Read more
TikTok parent ByteDance eyes $330bn valuation as sales leap past Meta
TikTok parent ByteDance eyes $330bn valuation as sales leap past Meta ByteDance, the Chinese owner...
H.I.G. Capital exits EYSA after rapid three-year transformation with sale to Tikehau
H.I.G. Capital exits EYSA after rapid three-year transformation with sale to Tikehau H.I.G....
Crescent Capital joins wave of $3bn credit continuation funds
Crescent Capital joins wave of $3bn credit continuation funds Crescent Capital Group is preparing...